A Phase II Study Using Low Dose Radiotherapy as a Chemosensitizer for Adavanced/Persistent Squamous Cell Carcinoma

Grants and Contracts Details

StatusFinished
Effective start/end date9/5/022/28/05

Funding

  • Bristol Myers Squibb Company: $10,000.00